TER Stock Analysis: Teradyne | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 60.174m USD | 12M Return: 263.3% | US8807701029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.19B
EPS Trend: 77.5%
Qual. Beats: 4
Rev. Trend: 80.2%
Qual. Beats: 4
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Teradyne, Inc. is a U.S.-based provider of automated test systems and robotics products, operating across the Americas, Asia Pacific, and EMEA through three main segments: Semiconductor Test, Robotics, and Other. The Semiconductor Test segment supplies wafer-level, device package, and system-level testing solutions for a wide range of end markets including automotive, industrial, communications, consumer electronics, smartphones, cloud computing, and gaming, serving integrated device manufacturers, fabless firms, foundries, and outsourced assembly and test providers. Key product lines include the FLEX test platform, J750 test system, Magnum memory test platform, and ETS analog/mixed-signal platform.
The Robotics segment offers collaborative robotic arms and autonomous mobile robots aimed at manufacturing, logistics, and industrial customers, while the Other segment covers defense/aerospace test, circuit-board test, wireless test systems, and silicon photonics testing. Teradyne has a strategic collaboration with Tokyo Electron Limited to develop test cell solutions for AI and data center applications, reflecting the growing importance of semiconductor test equipment in high-performance computing. Founded in 1960 and headquartered in North Reading, Massachusetts, the company operates within the Semiconductor Materials & Equipment industry, where automated test equipment (ATE) is a critical link in the semiconductor supply chain, validating chip functionality before deployment.
- AI data center chip testing demand accelerates Semiconductor Test bookings
- Robotics segment weakness pressures margins as Universal Robots orders decline
- Automotive chip electrification drives long-term test demand
| Net Income: 1.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 1.12 > 1.0 |
| NWC/Revenue: 28.06% < 20% (prev 32.12%; Δ -4.07% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.06b > Net Income 1.15b |
| Net Debt (-254.7m) to EBITDA (1.45b): -0.18 < 3 |
| Current Ratio: 2.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.7m) vs 12m ago -2.11% < -2% |
| Gross Margin: 59.31% > 18% (prev 59.14%; Δ 0.18% > 0.5%) |
| Asset Turnover: 102.8% > 50% (prev 75.17%; Δ 27.60% > 0%) |
| Interest Coverage Ratio: 105.2 > 6 (EBIT TTM 1.35b / Interest Expense TTM 12.8m) |
| A: 0.25 (Total Current Assets 2.37b - Total Current Liabilities 1.11b) / Total Assets 4.93b |
| B: 0.28 (Retained Earnings 1.40b / Total Assets 4.93b) |
| C: 0.31 (EBIT TTM 1.35b / Avg Total Assets 4.34b) |
| D: 2.37 (Book Value of Equity 3.44b / Total Liabilities 1.45b) |
| Altman-Z'' = 7.17 = AAA |
| DSRI: 1.62 (Receivables 1.11b/433.0m, Revenue 4.46b/2.83b) |
| GMI: 1.00 (GM 59.14% / 59.31%) |
| AQI: 0.90 (AQ_t 0.37 / AQ_t-1 0.41) |
| SGI: 1.58 (Revenue 4.46b / 2.83b) |
| TATA: 0.02 (NI 1.15b - CFO 1.06b) / TA 4.93b) |
| Beneish M = -2.16 (Cap -4..+1) = BB |
As of August 10, 2026, the stock is trading at USD 379.31 with a total of 3,551,320 shares traded. Over the past week, the price has changed by +3.16%, over one month by +4.57%, over three months by +3.49% and over the past year by +263.28%.
Current recommended Stop Loss: 324.20 (which is 14.5% or 1.7 ATR below the current price).
Teradyne has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy TER.
- StrongBuy: 9
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 449.8 | 18.6% |
P/E Trailing = 53.4569
P/E Forward = 43.1034
P/S = 13.4797
P/B = 18.3561
P/EG = 1.0277
Revenue TTM = 4.46b USD
EBIT TTM = 1.35b USD
EBITDA TTM = 1.45b USD
Long Term Debt = 82.9m USD (estimated: total debt 100.1m - short term 17.3m)
Short Term Debt = 17.3m USD (from shortTermDebt, last quarter)
Debt = 100.1m USD (from shortLongTermDebtTotal, last quarter) (leases 100.1m already included)
Net Debt = -254.7m USD (calculated: Debt 100.1m - CCE 354.8m)
Enterprise Value = 59.9b USD (60.2b + Debt 100.1m - CCE 354.8m)
Interest Coverage Ratio = 105.2 (Ebit TTM 1.35b / Interest Expense TTM 12.8m)
EV/FCF = 74.91x (Enterprise Value 59.9b / FCF TTM 799.9m)
FCF Yield = 1.34% (FCF TTM 799.9m / Enterprise Value 59.9b)
FCF Margin = 17.92% (FCF TTM 799.9m / Revenue TTM 4.46b)
Net Margin = 25.77% (Net Income TTM 1.15b / Revenue TTM 4.46b)
Gross Margin = 59.31% ((Revenue TTM 4.46b - Cost of Revenue TTM 1.82b) / Revenue TTM)
Gross Margin QoQ = 59.79% (prev 60.89%)
Tobins Q-Ratio = 12.16 (Enterprise Value 59.9b / Total Assets 4.93b)
Interest Expense / Debt = 12.83% (Interest Expense 12.8m / Debt 100.1m)
Taxrate = 13.70% (183.4m / 1.34b)
NOPAT = 1.17b (EBIT 1.35b * (1 - 13.70%))
Current Ratio = 2.12 (Total Current Assets 2.37b / Total Current Liabilities 1.11b)
Debt / Equity = 0.03 (Debt 100.1m / totalStockholderEquity, last quarter 3.44b)
Debt / EBITDA = -0.18 (Net Debt -254.7m / EBITDA 1.45b)
Debt / FCF = -0.32 (Net Debt -254.7m / FCF TTM 799.9m)
Total Stockholder Equity = 3.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 26.48% (Net Income 1.15b / Total Assets 4.93b)
RoE = 38.04% (Net Income TTM 1.15b / Total Stockholder Equity 3.02b)
RoCE = 43.52% (EBIT 1.35b / Capital Employed (Equity 3.02b + L.T.Debt 82.9m))
RoIC = 32.36% (NOPAT 1.17b / Invested Capital 3.61b)
WACC = 15.50% (E(60.2b)/V(60.3b) * Re(15.51%) + D(100.1m)/V(60.3b) * Rd(12.83%) * (1-Tc(0.14)))
Discount Rate = 15.51% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -90.85 | Cagr: -1.29%
[DCF] Terminal Value 58.31% ; FCFF base≈707.5m ; Y1≈811.1m ; Y5≈1.19b
[DCF] Fair Price = 51.84 (EV 7.85b - Net Debt -254.7m = Equity 8.10b / Shares 156.3m; r=15.50% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 77.49 | EPS CAGR: 30.26% | SUE: 2.57 | # QB: 4
Revenue Correlation: 80.23 | Revenue CAGR: 15.31% | SUE: 2.90 | # QB: 4
EPS current Quarter (2026-09-30): EPS=2.05 | Chg30d=+42.84% | Revisions=+29% | Analysts=15
EPS current Year (2026-12-31): EPS=9.09 | Chg30d=+24.87% | Revisions=+38% | GrowthEPS=+129.6% | GrowthRev=+61.2%
EPS next Year (2027-12-31): EPS=11.55 | Chg30d=+18.53% | Revisions=+44% | GrowthEPS=+27.1% | GrowthRev=+21.0%
[Analyst] Revisions Ratio: +50% (up=12, down=3)